<DOC>
	<DOCNO>NCT00790998</DOCNO>
	<brief_summary>This Phase 3 study compare efficacy , safety tolerability moxidectin ivermectin subject infect Onchocerca volvulus , parasite cause river blindness . Subjects participate study randomly assign ( 2 to1 ratio ) receive one orally-administered dose either moxidectin ivermectin .</brief_summary>
	<brief_title>Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection</brief_title>
	<detailed_description />
	<mesh_term>Onchocerciasis</mesh_term>
	<mesh_term>Intestinal Volvulus</mesh_term>
	<mesh_term>Milbemycin</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Male female subject Onchocerca volvulus infection Pregnant breast feed woman ; coincidental loiasis</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>onchocerciasis</keyword>
	<keyword>river blindness</keyword>
	<keyword>onchocerca volvulus</keyword>
	<keyword>moxidectin</keyword>
	<keyword>ivermectin</keyword>
</DOC>